Agitated depression symptoms

Amoxapine Relief of depressive symptoms in patients with neurotic or reactive depressive disorders and endogenous and psychotic depression depression accompanied by anxiety or agitation. 

The most frequent adverse reactions reported are sedation, followed by dizziness, weakness and unsteadiness. Less frequent adverse reactions include disorientation, depression, nausea, change in appetite, headache, sleep disturbance, agitation, dermatological symptoms including very serious reactions, eye-function disturbance, together with various gastrointestinal symptoms and autonomic manifestations. The incidence of sedation and unsteadiness increases with age. 

Benzodiazepines (BZDs) have been used for the treatment of depression because their sedative effects can reduce insomnia, agitation, and anxiety symptoms that frequently accompany depressed states. Considerable evidence also indicates that major depression may accompany panic and agoraphobic disorders ( 199, 200 and 201). When depression precedes the onset of panic disorder, clinical experience suggests a better response to antidepressants than to BZDs, although no studies have directly addressed this issue (202). Conversely, available evidence indicates that when depression occurs after the onset of panic disorder, treatment with either a BZD or a tricyclic may result in concomitant improvement of both the panic and depressive symptoms (198, 199, 200, 201,202 and 203). Depression, however, has been reported to be an adverse effect of BZD treatment. 

Affective Group. Conventional TCAs have had a variable and sometimes lackluster effect on the depressive symptoms seen in BPD. Indeed, some studies indicate that these drugs may worsen symptoms, particularly by increasing irritability and agitation (238). By contrast. Cole et al. (239) did a retrospective evaluation of drug response in patients with BPD and major depression, noting that five of six who received TCAs responded, whereas BPD patients without depression treated with a TCA did not respond. 

In another three cases (girls aged 10, 13, and 15 years) severe acute psychosis was associated with the use of an over-the-counter formulation containing ephedrine or pseudoephedrine and dextromethorphan combined with other compounds (225). The psychopathology included agitation, depressed mood, flat affect, pressure of speech, visual and auditory hallucinations, and paranoia. All three improved dramatically, with residual symptoms of irritability, 2-4 days after withdrawal of the mixture and treatment with risperidone 0.5-2.0 mg/day. 

Many other commonly used antibiotics can cause psychiatric symptoms, for example, clarithromycin (trade name, Biaxin)—which is frequently used to treat respiratory illness, ear infections, and skin infections—has been reported to cause mania in some patients. Metronidazole (trade name Flagyl), which is used to treat many types of infections—from parasites to vaginal infections and abscesses—has been reported to cause depression, agitation, confusion, hallucinations, and mania. Trimethoprim-sulfamethoxazole (trade names Bactrim and Septra)—which is used, for example, for bladder infections and sinus and ear infections—has been reported to cause delirium, psychosis, depression, and hallucinations in rare cases. The fluoroquinolone antibiotics—such as ciprofloxacin (trade name Cipro), levofloxacin (trade name Levaquin), ofloxacin (trade name Floxin), trovafloxacin (trade name Trovan), and others of this class—can cause psychiatric symptoms fairly often, including confusion, agitation, depression, insomnia, mania, paranoia, and psychosis. 

A respiratory and CNS depressant symptoms of acute inhalation may include nausea, euphoria, ataxia, dizziness, agitation, and lethargy severe exposure will lead to respiratory arrest, seizures, and coma Dizziness, excitement, flushing of the face, drowsiness, poor coordination, tremor, confusion, respiratory depression, and coma... 

Certainly, anxiety symptoms are seen in a very wide range of psychiatric disorders, including schizophrenia, mania, PTSD, agitated depressions, and severe personality disorders. It is important to keep in mind that anxiety symptoms do not necessarily signal a diagnosis of anxiety disorder. Almost without exception, however, when anxiety is associated with a more primary mental disorder, psychotropic medication treatment is aimed at the primary disorder. (Refer to appropriate chapters for descripfions of efiology and treatment.)... 

The medications known as anticonvulsants are often used as front-line treatment of the bipolar disorders. The most common of these medications include Tegretol (carbamazepine), Depakene or Depakote (valproate or valproic acid), and Klonopin (clonazepam), and they are used under the following circumstances (a) inadequate response or intolerance to antipsy-chotics or lithium (b) manic symptoms (c) rapid cycling of the condition (d) EEG abnormalities and (e) head trauma (Kaplan Sadock, 1996). In practice, these medications seem particularly effective for clients who suffer from schizoaffective disorders or agitated depression of a cyclic nature. They are considered the medication of choice if an individual has a history of brain damage or of severe or rapid mood swings (Dulcan, 1999). Furthermore, if an individual has atypical features of the mental... 

Unfortunately, no routine tests exist that can measure levels of brain chemicals—at least, not yet. But we can infer these levels by the types of depression and the clusters of symptoms that people manifest. Depending on which chemicals are imbalanced, you may tend toward anxious depression, agitated depression, or sluggish depression, each of which is a relatively distinct syndrome with its own behaviors and personality characteristics. 

Symptoms of Excess Dopamine/Norepinephrine, or Agitated Depression ... 

Antipsychotic medications are indicated in the treatment of acute and chronic psychotic disorders. These include schizophrenia, schizoaffective disorder, and manic states occurring as part of a bipolar disorder or schizoaffective disorder. The co-adminstration of antipsychotic medication with antidepressants has also been shown to increase the remission rate of severe depressive episodes that are accompanied by psychotic symptoms. Antipsychotic medications are frequently used in the management of agitation associated with delirium, dementia, and toxic effects of both prescribed medications (e.g. L-dopa used in Parkinson s disease) and illicit dtugs (e.g. cocaine, amphetamines, andPCP). They are also indicated in the management of tics that result from Gilles de la Tourette s syndrome, and widely used to control the motor and behavioural manifestations of Huntington s disease. 

Although rare, benzodiazepine toxicity may occur from an overdose of the drug. Benzodiazepine toxicity causes sedation, respiratory depression, and coma. Flumazenil (Romazicon) is an antidote (antagonist) for benzodiazepine toxicity and acts to reverse die sedation, respiratory depression, and coma within 6 to 10 minutes after intravenous administration. The dosage is individualized based on the patient s response, widi most patients responding to doses of 0.6 to 1 mg. However, die drug s action is short, and additional doses may be needed. Adverse reactions of flumazenil include agitation, confusion, seizures, and in some cases, symptoms of benzodiazepine withdrawal. Adverse reactions of flumazenil related to the symptoms of benzodiazepine withdrawal are relieved by die administration of die benzodiazepine. 

Differentiating between depression and dementia can be difficult, so symptoms of depression should be documented for several weeks prior to initiating therapy for the treatment of depression with AD. Citalopram and sertraline are recommended as first-line agents because of their efficacy in placebo-controlled trials.49 Indications for the use of antidepressants include depression characterized by poor appetite, insomnia, hopelessness, anhedonia, withdrawal, suicidal thoughts, and agitation. 

Pediatric patients should be observed closely for suicidality, worsened depression, agitation, irritability, and unusual changes in behavior, especially during the initial few months of therapy or at times of dosage changes. Furthermore, families and caregivers should be advised to monitor patients for such symptoms. 

Antidepressant medications appear to be useful for certain children and adolescents, particularly those who have severe or psychotic depression, fail psychotherapeutic measures, or experience chronic or recurrent depression. SSRIs generally are considered the initial antidepressants of choice, although comorbid conditions may favor alternative agents. Clinicians should be aware of the possibility of behavioral activation with the SSRIs, including such symptoms as impulsivity, silliness, daring conduct, and agitation.44 Desipramine should be used with caution in this population because of several reports of sudden death, and a baseline and follow-up electrocardiogram (ECG) may be warranted when this medication is used to treat pediatric patients.9... 

Now there are a number of problems with relapse-prevention studies. One is the fact that many people who are taken off antidepressants experience withdrawal symptoms, which in severe cases can last for months. Some of these withdrawal symptoms - sadness, suicidal thoughts, crying spells, trouble concentrating, irritability, anxiety, agitation and insomnia, for example - are also symptoms of depression.12 These withdrawal symptoms could lead both patients and researchers to think that the patient has relapsed. 

---